There was an apparent synergistic effect among LIPT1, LIAS, GLS, DBT, ATP7A, and DLAT, and a robust antagonistic effect between CDKN2A and LIPT1, LIAS, GLS, DBT, ATP7A, and DLAT in IPF patients. The gene discussed is DLAT; the disease is idiopathic pulmonary fibrosis.